EURENSA developed new innovant services for clinical studies environement.

• Fundraising for clinical studies
• Feasibility (F2F, surveys, PMSI feasibility study)
• Investigators selection via our callcenter and web tools
• Animated films from studies (Doctors / patients)
• Multi-language remote monitoring
• Patient follow-up ; on line or by phone (Logistic, PRO, Patient diary card)
• TEC network
• Molecular modeling of mechanisms of action
• Pharmacoeconomics: integration of Pharmacoepidemiology economics models.In France,EURENSA has access to the PMSI base and a network of pharmacists and doctors DIM. (PMSI is a database where all activity done in France by hospital or  health establishment is registred by pathology, medical and surgeary acts, treatments,..per each patient). By extrapolation we are able to modelize activity in Europe.